Incentive scheme Release no. 17/2014 To

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Incentive scheme

Release no. 17/2014

To strengthen Columbus A/S’s results and value creation for the company’s share­holders, and to attract, retain and motivate senior executives, the Board of Directors has decided to exercise the authorization in Art. 5 in the Company’s Articles of Association and grant warrants amounting to a total value of DKK 3,825,000 (nom.) to senior executives in Columbus A/S.

The issue of warrants is in accordance with the Company’s guidelines for incentive programs which were adopted at the Company’s Annual General Meeting on 25 April 2015.

The exercise price is based on the average quoted share price in the 3 trading days prior to the grant date.

The share warrants are granted to senior executives and other senior employees contingent on employment in the company in the below-mentioned vesting periods. 

The share warrant scheme will not be adjusted in the event of changes in capital.

Share warrants based on employment and EBITDA:

Period Right to subscribe shares at DKK 1.25 (nom.) per share Conditions
January 1st 2016 – December 31st 2016: 1,020,000 shares at DKK 5.45 per share Employment in Columbus A/S at December 31st 2016
January 1st 2017 – December 31st 2017: 1,020,000 shares at DKK 5.45 per share Employment in Columbus A/S at December 31st 2017
January 1st 2018 – December 31st 2018: 1,020,000 shares at DKK 5.45 per share Employment in Columbus A/S at December 31st 2018

If all warrants are exercised, the total capital increase will amount to DKK 1,245,000 (nom.), corresponding to 3,060,000 shares of DKK 1.25.

The exercise periods are scheduled to the first 14 days after publication of the company’s first financial statements succeeding expiry of the relevant vesting periods. The first exercise period is scheduled to the first 14 days after publication of the company’s financial statements for 2016. The second exercise period is scheduled to the first 14 days after publication of the company’s financial statements for 2017. The third exercise period is scheduled to the first 14 days after publication of the company’s financial statements for 2018.  

On the basis of Black & Scholes’ calculation, the total market value forecast of the scheme is up to DKK 2.8m which will be expensed in 2016, 2017 and 2018.

Following the grant DKK 4,930,000 of the nominal value will remain of the Board’s authorization to issue warrants.

Ib Kunøe                                  Thomas Honoré

Chairman                                CEO & President

Columbus A/S              Columbus A/S

For further information, please contact:

CEO Thomas Honoré, T: +45 70 20 50 00.

Translation: In the event of any inconsistency between this document and the Danish language version, the Danish language version shall be the governing version.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 5

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 0

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 6

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 9

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 0

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 0

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 1

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 8

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 1

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 1

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

AGNC Investment Prepares for Earnings Announcement

Updated Category News Views 42

Anticipating Earnings for AGNC Investment AGNC Investment (NASDAQ: AGNC) is gearing up to announce its quarterly earnings. Investors are eager to know the company's financial health and future outlook. According to analysts, AGNC Investment is projected to report an earnings per share (EPS) of $0.51 for this quarter. This figure is critical for investors tracking the...

Continue Reading
Foraco International Announces Q3 2024 Financial Results

Updated Category News Views 191

Foraco International Reports Third Quarter 2024 Results Foraco International SA (TSX:FAR), a prominent player in the global drilling industry, has just released its financial performance for the third quarter of 2024. The Company reported a total revenue of US$77.7 million, a decline from the record US$95.1 million achieved in the same quarter last year. The current...

Continue Reading
Exploring the Future of Transparent Conductive Film Displays

Updated Category News Views 115

Overview of Transparent Conductive Film Displays Transparent Conductive Film (TCF) Displays utilize a delicate, transparent conductive layer that supports touch functionality while preserving remarkable optical clarity. These films are pivotal in numerous applications, such as touchscreen displays, flexible electronics, OLEDs, and smart windows. They act as an electrode...

Continue Reading
Watsco Announces Substantial $3.00 Quarterly Dividend Payment

Updated Category News Views 175

Watsco Announces Substantial $3.00 Quarterly Dividend Payment Watsco, Inc. (NYSE: WSO) has recently declared a quarterly cash dividend of $3.00 per share on its Common and Class B common stock. The dividend is set to be paid on July 31 to shareholders recorded as of July 16. This payment underscores Watsco's long-standing commitment to returning value to its shareholders....

Continue Reading
Milliman Giving Fund Drives Clean Water Initiatives Globally

Updated Category News Views 134

Milliman Giving Fund’s Dedication to Global Health In a notable step toward enhancing global health and hygiene, Milliman, Inc., a well-respected consulting and actuarial firm, has launched a significant initiative through its Milliman Giving Fund. Recently, the organization granted a generous $750,000 to Splash International, committing this funding over the next three...

Continue Reading